Subscribe to our newslett...
Like to be kept up to date? Sign up to our bi-monthly newsletter here!
Webinar: Open questions a...
Face masks characterize the public spaces today. Together with other measures, such as social distancing, hand hygiene and contact tracing, masks actively contribute to fight the spread
Characterizing Nanopartic...
Live Webinar, Thursday 19 November, 15:00 (Zürich). Guest speaker Dr. Sandor Balog, Details, Please register for this event using this link
Country-scale calculation...
Plastic particles less than five millimeters in size, also known as microplastics, often settle far away from their point of origin. Empa researchers have now developed a
Reliable knowledge on nan...
contactpointnano.ch helps with questions about nanomaterials A new contact point for start-ups, SMEs and industry bundles the scientific and regulatory expertise in the field of nanotechnology available
Microplastics and Nanopla...
Recently, the European Commission published a study that provides further information on the intentional uses of microplastic particles in products and the risks they pose to human
Crucial results for coron...
Empa researcher Peter Wick, Head of the Particles-Biology Interactions Laboratory in St. Gallen and Director of contactpointnano.ch talks to Empa Quarterly about recent antibody studies, which are
Guidelines: Safe-by-desig...
A novel guideline document elaborated by the EU-consortium GoNanoBioMat and presented at the final dissemination event. The GoNanoBioMat framework is designed to elaborate current knowledge to small and medium-sized enterprises
Nanomedicine in Liverpool
contactpointnano was present at Nanomed Europe 23 in Liverpool (June 19-22). This event is organized by ETPN and it is the largest Nanomedicine event in Europe. The
Safe-by-design and EU fun...
Contribution of the EU NanoSafetyCluster (NSC), supporting the SbD-study of the European Commission, March 2021 Editors: Andreas Falk, Flemming R. Cassee and Eva Valsami-Jones
